Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


BOJ Signals Possible April Rate Hike as Ueda Eyes Inflation and Wage Growth Data
Nintendo Share Sale: MUFG and Bank of Kyoto to Sell Stakes in Strategic Unwinding
APEX Tech Acquisition Inc. Raises $111.97 Million in NYSE IPO Under Ticker TRADU
Anthropic Refuses Pentagon Request to Remove AI Safeguards Amid Defense Contract Dispute
Gold Prices Rebound as U.S. Tariffs, Fed Policy and Iran Talks Drive Market Sentiment
Greg Abel’s First Berkshire Hathaway Shareholder Letter Signals Continuity, Caution, and Capital Discipline
Meta Signs Multi-Billion Dollar AI Chip Deal With Google to Power Next-Gen AI Models
China’s New Home Prices Post Sharpest Drop Since 2022 Amid Ongoing Property Slump
BlueScope Steel Shares Drop After Rejecting Revised A$15 Billion Takeover Bid
Toyota Plans $19 Billion Share Sale in Major Corporate Governance Reform Move
Samsung Electronics Stock Poised for $1 Trillion Valuation Amid AI and Memory Boom
Trump Orders Federal Agencies to Halt Use of Anthropic AI Technology
Snowflake Forecasts Strong Fiscal 2027 Revenue Growth as Enterprise AI Demand Surges
OpenAI Pentagon AI Contract Adds Safeguards Amid Anthropic Dispute
Gold Prices Rally in February as Geopolitical Risks and Economic Uncertainty Boost Safe-Haven Demand
Samsung and SK Hynix Shares Hit Record Highs as Nvidia Earnings Boost AI Chip Demand
U.S. Stock Futures Fall as Nvidia Drops Despite Strong Earnings; Netflix Jumps 9% 



